27131339|t|HERG1 potassium channel expression in potentially malignant disorders of the oral mucosa and prognostic relevance in oral squamous cell carcinoma
27131339|a|HERG1 potassium channel plays a critical role in the cell proliferation. HERG1 protein expression was analyzed by immunohistochemistry (IHC) in 62 patients with oral leukoplakias and 100 patients with oral squamous cell carcinomas (OSCC). HERG1 mRNA levels were assessed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) in 22 patients with primary head and neck squamous cell carcinoma (HNSCC). Statistically significant associations were found between HERG1 expression and tobacco consumption, disease stage, tumor differentiation, tumor recurrence, and reduced survival. There was no association between HERG1 expression and the risk of progression from oral leukoplakia to OSCC. In addition, a high proportion of tumors (80%) showed increased HERG1 mRNA levels compared to normal mucosa from nononcologic patients. Aberrant HERG1 expression increases as oral tumorigenesis progresses from oral hyperplasia to OSCC. Increased HERG1 mRNA levels were also frequently detected in OSCC and other HNSCC subsites. HERG1 expression emerges as a clinically relevant feature during tumor progression and a potential poor prognostic biomarker for OSCC. Â© 2016 Wiley Periodicals, Inc. Head Neck 38: 1708-1716, 2016.
27131339	0	5	HERG1	T103	UMLS:C1566128
27131339	6	23	potassium channel	T103	UMLS:C0032824
27131339	24	34	expression	T038	UMLS:C1171362
27131339	50	69	malignant disorders	T038	UMLS:C0006826
27131339	77	88	oral mucosa	T017	UMLS:C0026639
27131339	93	103	prognostic	T170	UMLS:C0220901
27131339	117	145	oral squamous cell carcinoma	T038	UMLS:C0585362
27131339	146	151	HERG1	T103	UMLS:C1566128
27131339	152	169	potassium channel	T103	UMLS:C0032824
27131339	199	217	cell proliferation	T038	UMLS:C0596290
27131339	219	232	HERG1 protein	T103	UMLS:C1566128
27131339	233	243	expression	T038	UMLS:C1171362
27131339	248	256	analyzed	T062	UMLS:C0936012
27131339	260	280	immunohistochemistry	T058	UMLS:C0021044
27131339	282	285	IHC	T058	UMLS:C0021044
27131339	307	324	oral leukoplakias	T038	UMLS:C0023532
27131339	347	376	oral squamous cell carcinomas	T038	UMLS:C0585362
27131339	378	382	OSCC	T038	UMLS:C0585362
27131339	385	390	HERG1	T017	UMLS:C1416571
27131339	391	395	mRNA	T103	UMLS:C0035696
27131339	420	477	real-time reverse transcriptase-polymerase chain reaction	T062	UMLS:C0599161
27131339	479	485	RT-PCR	T062	UMLS:C0599161
27131339	515	552	head and neck squamous cell carcinoma	T038	UMLS:C1168401
27131339	554	559	HNSCC	T038	UMLS:C1168401
27131339	620	625	HERG1	T103	UMLS:C1566128
27131339	626	636	expression	T038	UMLS:C1171362
27131339	677	682	tumor	T038	UMLS:C0027651
27131339	683	698	differentiation	T038	UMLS:C0007589
27131339	700	716	tumor recurrence	T038	UMLS:C0521158
27131339	773	778	HERG1	T103	UMLS:C1566128
27131339	779	789	expression	T038	UMLS:C1171362
27131339	806	817	progression	T038	UMLS:C0178874
27131339	823	839	oral leukoplakia	T038	UMLS:C0023532
27131339	843	847	OSCC	T038	UMLS:C0585362
27131339	883	889	tumors	T038	UMLS:C0027651
27131339	913	918	HERG1	T017	UMLS:C1416571
27131339	919	923	mRNA	T103	UMLS:C0035696
27131339	943	956	normal mucosa	T017	UMLS:C0026724
27131339	994	999	HERG1	T103	UMLS:C1566128
27131339	1000	1010	expression	T038	UMLS:C1171362
27131339	1029	1053	tumorigenesis progresses	T038	UMLS:C0178874
27131339	1079	1083	OSCC	T038	UMLS:C0585362
27131339	1095	1100	HERG1	T017	UMLS:C1416571
27131339	1101	1105	mRNA	T103	UMLS:C0035696
27131339	1134	1142	detected	T033	UMLS:C0442726
27131339	1146	1150	OSCC	T038	UMLS:C0585362
27131339	1161	1166	HNSCC	T038	UMLS:C1168401
27131339	1167	1175	subsites	T082	UMLS:C1710234
27131339	1177	1182	HERG1	T103	UMLS:C1566128
27131339	1183	1193	expression	T038	UMLS:C1171362
27131339	1242	1259	tumor progression	T038	UMLS:C0178874
27131339	1281	1291	prognostic	T170	UMLS:C0220901
27131339	1292	1301	biomarker	T201	UMLS:C0005516
27131339	1306	1310	OSCC	T038	UMLS:C0585362